Ionis Pharmaceuticals, Inc.
IONS
$32.53
-$1.01-3.00%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -40.81% | 25.72% | -112.00% | 53.60% | -1,441.65% |
| Total Depreciation and Amortization | 2.47% | -4.11% | -1.54% | -1.27% | 0.69% |
| Total Amortization of Deferred Charges | -1.91% | -0.24% | 0.42% | 0.24% | 0.18% |
| Total Other Non-Cash Items | -28.97% | 59.29% | -19.25% | 6.74% | 42.08% |
| Change in Net Operating Assets | 32.92% | -625.68% | 91.00% | -106.56% | -450.53% |
| Cash from Operations | -29.82% | -1.00% | 4.08% | 20.05% | -556.22% |
| Capital Expenditure | 50.67% | -181.55% | -45.27% | -38.75% | -648.60% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 95.32% | 128.25% | -582.99% | -14.78% | 392.74% |
| Cash from Investing | 149.89% | 120.02% | -645.71% | -17.94% | 384.90% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 99.91% | -92,702.08% | -23.08% | 0.00% | -2.63% |
| Issuance of Common Stock | 422.38% | -99.91% | 19,009.98% | -89.00% | -42.08% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 104.98% | -108.89% | 19,299.57% | -89.15% | -42.12% |
| Foreign Exchange rate Adjustments | 147.74% | -238.86% | 1,621.74% | 79.82% | -134.55% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 123.90% | -327.83% | 173.98% | -8.97% | -206.72% |